By continuing to browse the site you are agreeing to our use of cookies and similar tracking technologies described in our privacy policy.

Sofosbuvir/Velpatasvir in Combination With Ribavirin for 24 Weeks Is Effective Retreatment for Patients Who Failed Prior NS5A-Containing DAA Regimens: Results of the Retreatment Study

Journal

51st Annual Meeting of the European Association for the Study of the Liver (EASL). April 13-17.

Year of Publication

2016

Authors

Type of Article

Conference Paper